Conference Report

Conference Report From 2006 Prostate Cancer Symposium

Source: CCO Independent Conference Coverage of the 2006 ASCO Prostate Cancer Symposium*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Conference Report From 2006 Prostate Cancer Symposium

Faculty:
Tomasz M. Beer, MD James A. Eastham, MD

CME CREDIT INFORMATION

Release Date: 04/28/06

Expiration Date: 04/27/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Review clinical data regarding the utility of chemotherapy in the treatment of prostate cancer
Discuss the benefits and risks of salvage therapies in the setting of localized disease relapse
Identify new approaches and regimens currently being studied for the treatment of advanced prostate cancer

Topics covered include:

Overview
Prostate Cancer Etiology May Be Infectious in Some Men
Obesity and Prostate Cancer
Serum PSA as a Screening Tool for Prostate Cancer
The Surgeon as a Independent Predictor of Biochemical Recurrence
Options in Early-Stage Prostate Cancer
Bisphosphonates Prevent and Treat ADT-Associated Osteoporosis
Docetaxel Chemotherapy Benefits Selected Prostate Cancer Patients
Estrogens Active as a Second-Line Hormonal Treatment for Prostate Cancer
CTLA-4 Antibody Immunotherapy
Repeated Doses of Samarium-153 Appear Safe

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.